89Zr-DFO-GmAb PET/CT
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for 89Zr-DFO-GmAb PET/CT, covering 2025-06-12 to 2025-06-12. Get the full timeline:
Most recent: Clinical Trial Update: An Investigational Scan (89Zr-DFO-GmAb PET/CT) Compared to Contrast-Enhanced CT for the Detection of Recurrent Clear Cell Renal Cell Cancer After Surgery Comparing Carbonic Anhydrase IX (CAIX) PET CT to Conventional PET CT for Post-Op Staging in Kidney Cancer [Phase 2]